Pulmonary Hypertension

Why trials studying Pulmonary Hypertension stopped, in this sample of ClinicalTrials.gov.

18 stopped trials with a clear reason; 100% ended for non-scientific reasons.

Trials

• Differential Diagnosis of Pulmonary Hypertension With Automated Image Analysis
  NCT04329312 · TERMINATED · slow accrual
  “slow recruitment”
• Screening of Pulmonary Hypertension in Methamphetamine Abusers
  NCT04019600 · SUSPENDED · logistics pi
  “Recruitment in out-patient clinic has been suspended due to COVID-19 pandemic”
• Prognostic Impact of the Evolution of PAH 3 Months After TAVI (HTP-TAVI)
  NCT04008550 · TERMINATED · slow accrual
  “* Delay in enrolment (24% at 1 year) * Lower than estimated prevalence of PAH (15% instead of 50%) * Refusal of patients with PAH to participate”
• Effects of Automated Oxygen Titration Alone or With High Flow Nasal Therapy on Dyspnea and Exercise Tolerance
  NCT05267418 · TERMINATED · logistics pi
  “COVID19 pandemia”
• Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER
  NCT03068130 · TERMINATED · logistics pi
  “The company determined that continued exposure of these high-risk PH patients to clinic or in-person visits during the COVID pandemic presented an unacceptable risk.”
• Impact of Availability of Showerpatch for Patients With Intravenous Catheters
  NCT02324868 · TERMINATED · logistics pi
  “logistic problems”
• A Pilot Study Evaluating Heart and Lung Metabolism in Pulmonary Hypertension Associated With Left Heart Disease
  NCT02237378 · TERMINATED · slow accrual
  “Poor enrolment”
• Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc)
  NCT02246348 · TERMINATED · slow accrual
  “Low recruitment rate”
• Vasopressin and Inhaled Prostacyclin in Pediatric Pulmonary Hypertension
  NCT01370096 · TERMINATED · slow accrual
  “Difficulty with patient recruitment”
• Anticoagulation For Pulmonary Hypertension in Sickle Cell Disease
  NCT01036802 · TERMINATED · slow accrual
  “Difficulty in accruing subjects”
• Safety and Efficacy Study of Bosentan in Progressive Pulmonary Sarcoidosis
  NCT00926627 · TERMINATED · slow accrual
  “Not enough patients with the specified criteria could not”
• Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentan
  NCT00840463 · TERMINATED · slow accrual
  “Poor enrolment”
• Inhaled PGE1 in Neonatal Hypoxemic Respiratory Failure
  NCT00598429 · WITHDRAWN · slow accrual
  “Withdrawn due to lack of recruitment”
• Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil
  NCT00625079 · WITHDRAWN · slow accrual
  “inclusion/exclusion criteria limited enrollment”
• Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.
  NCT00409526 · TERMINATED · logistics pi
  “Sub-Investigator left U of C”
• Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH)
  NCT00310830 · TERMINATED · slow accrual
  “Slow enrollment”
• A Pilot Study of Chronic Red Blood Cell Transfusion in Sickle Cell Disease-Associated Pulmonary Hypertension
  NCT00850369 · WITHDRAWN · slow accrual
  “Slow accrual onto the study”
• Natrecor in Pulmonary Hypertension
  NCT00075179 · TERMINATED · slow accrual
  “Low accrual.”

Reasons are labeled automatically and are unverified. See the methodology. This is research information, not medical advice. Search the full database.